Elsevier

Medical Hypotheses

Volume 142, September 2020, 109827
Medical Hypotheses

COVID-19: beta-thalassemia subjects immunised?

https://doi.org/10.1016/j.mehy.2020.109827Get rights and content

Abstract

The novel coronavirus pneumonia (COVID-19) is a contagious acute respiratory infectious disease whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent PRE-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia results of a default in the hemoglobin beta-chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research.

Keywords

Novel coronavirus
Respiratory distress
Favipiravir
Statistics
Correlation
Beta thalassemia
Immunization
Italy
Sardinia
Regression
Heme

Cited by (0)

View Abstract